B/D HPP
Initiative for Model Organisms Proteomics (iMOP)
GET INVOLVED: Get in touch at office@hupo.org to learn more
Mission & Goals
Our overall aim is to promote the emergence of new model organisms. In particular, we consider organisms as models when they are suitable for i) the study of biological mechanisms important to human health and disease, ii) a better understanding of pathogenicity, pathogen reservoirs, and the emergence of resistance, and iii) deciphering the toxic effects of pollutants and exposomes on biological systems in order to define sentinels of our environment, or to be relevant to the One-Health concept. Furthermore, iMOP will allow for the characterization of non-referenced proteins across various models.
Initiated in 2010, iMOP is at the forefront of Evolutionary Biology, Medicine, Environmental Proteomics, and Ecotoxicology. Through innovative approaches using comparative proteomics, proteogenomics, and (eco)toxicoproteomics, our initiative fosters collaborations between biologists and multi-omics specialists. By promoting multidisciplinary approaches, we tackle new challenging scientific questions and strive to enhance human health, environmental quality, and biodiversity conservation.
Researchers interested in our work are welcome to join us at every time. In particular we would like to motivate also early career researchers to join our team.
iMOP Membership
Leadership Information
Chair:
Daniel Martins-de-Souza, Ph.D
University of Campinas, Sao Paulo, Brazil
Co-Chair:
Sabine Matallana-Surget, Ph.D
University of Stirling, UK
Co-Chair:
Susana Cristobal, Ph.D
Linköping University, Sweden
Co-Chair:
Andreas Tholey, Ph.D
Kiel University, Germany
Co-Chair:
Jean Armengaud, Ph.D
Paris-Saclay University, CEA, France
Early Career Researcher:
Tristan Cardon, Ph.D
Inserm, University of Lille, France
Current Lines of Work
- Promote the development of bioinformatics resources to improve comparisons between species and better link proteins from model organisms to human diseases (from possible new therapeutic targets to potentially new biologics)
- Promote proteogenomics and multi-omics approaches, the improvement of genome annotations, and identification of the functions of proteoforms and non-canonical proteins
- Promote proteomic studies in any model organism relevant to improving human health and environmental monitoring within the One-Health framework
Stimulate collaborations between biology and Omics communities
Promote iMOP visibility in publications and conferences.
Must Read iMOP Publications:
Diversifying the concept of model organisms in the age of –omics
- Bertile F, Matallana-Surget S, Tholey A, Cristobal S, Armengaud J (2023). Commun Biol, 6(1): 1062.
We are not alone: The iMOP initiative and its roles in a Biology and Disease driven Human Proteome Project
- Tholey A, Taylor NL, Heazlewood JL, Bendixen E (2017). J Proteome Res, 16: 4273-4280
Multi-organism proteomes (iMOP): advancing our understanding of human biology
- Heazlewood JL, Schrimpf SP, Becher D, Riedel K, Proteomics, 15: 2885-2894 Tholey A, Bendixen E (2015).